CVS To Pay $36.7M To Settle Whistleblower Claims
CVS Caremark Corp. has agreed to pay $36.7 million to settle claims that the retail pharmacy giant switched patients to a more expensive version of the prescription drug ranitidine in order...To view the full article, register now.
Already a subscriber? Click here to view full article